Subscribe
Subscribe
药明康德
WuXi AppTec is a global pharmaceutical, biopharmaceutical, and medical device outsourcing company.
WuXi AppTec, founded in December, 2000 and headquartered in Wuxi, is Ge Li. The founder is Ge Li. Listed on the HKEX on December 13, 2018, the company's major shareholders are HKSCC Nominees Ltd, G&C VI Ltd and Summer Bloom Investments (I) PTE. Ltd. Rivals that have direct and indirect competition with WuXi AppTec include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
WuXi AppTec is a global pharmaceutical, biopharmaceutical, and medical device outsourcing company.
WuXi AppTec, founded in December, 2000 and headquartered in Wuxi, is Ge Li. The founder is Ge Li. Listed on the HKEX on December 13, 2018, the company's major shareholders are HKSCC Nominees Ltd, G&C VI Ltd and Summer Bloom Investments (I) PTE. Ltd. Rivals that have direct and indirect competition with WuXi AppTec include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
TC Medical's 1H 2020 Revenue Totals CNY 738 Mn, Down 12.87% YoY
France-China Cooperation Fund Closes First Deal in Dutch Ophthalmic Expert
Liquid Biopsy Developer Huidu Medical Closes Series B-1 for Precise Biomarker
Chinese Genetic-tech Gomics Closes Pre-Series A to Commerce
Continuous Glucose Monitor Maker Infinovo Closes Series B
Public Funds' Allocation to the Pharmaceutical Industry Reaches Record High
Health Monitor App Xiyou Closes Series A to Build New Pharma Retail Ecosystem
Mingdu Tech Closes Series A+ of CNY 80 Mn for Digitalization in Life Science
Wider Health Insurance Coverage Benefits Online Healthcare Business
JW Therapeutics Buys Hong Kong Anti-cancer Drug Maker Syracuse Biopharma
Medtronic Invests in Beijing Surgical Robots Maker Sinovation
Ali Health Denies Alibaba Selling Shares Rumor
Alibaba Sells 154 Million Ali Health Shares
Per Capita Healthcare Spending in China Decreases by 9.9% in H1 2020
HKEX-listed Venus MedTech Engages inMedical Investment
HKEX-listed Chinese Double Medical Gets CE Marked
Junshi Biosciences Lands on Star Market, Raising CNY 4.497 Bn
Heart Voice Closes Pre-Series A to Inject AI into Electrocardiograph
Salubris Pharma Forecasts Over 65% Drop in Net Profit
Hillhouse Will Inject USD 1 billion in BeiGene's Share Sale
EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.
We strive to make technology inclusive, accessible and transparent.
Join over 70,000 of your peers
Beijing
9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai
A002, 5F, Ai Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China
New York
800 Third Ave, 28F, New York, NY 10022, USA
Cooperation strategy
Products & prices
Customers & evaluation
